LGALS3

Golden Cross event and heavy insider buying on GALT

做多
NASDAQ:GALT   Galectin Therapeutics Inc.

  • Golden Cross formed
  • CEO takes 80% pay in stock
  • Billonaire chairman provided financing
  • Developing the leading drug candidate for advanced liver disease
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。